Agilent Technologies launches its latest microarray solution for
analysing activity at regulatory regions of genomes, enabling
researchers to examine gene regulation in a more efficient and
cost-effective manner.
Arsenal Capital Partners has acquired a majority stake in Reilly
Industries for €209 million and Velsicol Chemical for an
undisclosed fee. The purchases continue a rich vein of activity for
the private equity firm, which now hold...
Millipore, a maker of purification systems used in drug
manufacturing, reported lower third-quarter profit due to
acquisition-related tax charges and manufacturing consolidation
costs.
Malvern Instruments and Leeds University have formed a long-term
partnership to launch 'IntelliSense,' - a programme that will help
to deliver the next generation of sensors and control solutions,
creating opportunities...
A new UK-listed company that has developed a way of producing high
purity calcium carbonate is targeting the pharmaceutical industry
concerned by growing regulatory pressure on heavy metal
contamination.
Medisyn Technologies has entered into agreement with Humanetics
that aims to drive the discovery of natural compounds that can
offer safe, natural therapeutic options in the areas of obesity,
immune system and cognitive function.
The first melatonergic antidepressant to offer a new approach to
the treatment of depression is just over the horizon after new data
demonstrated positive efficacy with marked improvements in sleep
with no effect on daytime vigilance.
Animal rights activists, who engage in acts of violence, could be
prosecuted under new anti-terror legislation proposals outlined by
the Government that aim to crack down on recent attacks on British
Universities with animal research...
Benetic has announced the signing of two major agreements, one that
grants Sigma-Aldrich license for the use of Benitec's RNAi
technology. Sigma's acquisition of an equity stake in Benitec also
signals its intentions regarding...
Serono has announced a mixed third quarter 2005 with product sales
and total revenues weaker than predicted. Its net income beat
market consensus but the company was hit by an $18.3 million (€15.2
million) one-off charge related to...
In response to the increasing demand for high potency APIs,
Omnichem is increasing its Class V handling capabilities with an
expansion of their facility in Louvain-la-Neuve, Belgium.
The interest in Syntonix' SynFusion and Transceptor technologies
intensified as Boehringer Ingelheim became the second
pharmaceutical company to use this technology to optimise its
therapeutic peptides for inhalation.
Novasep Process launches its latest Supercritical Fluid
Chromatography unit, which aims to cut time and operating costs by
incorporating an automated CO2 recycling feature making it suitable
for purification process development, laboratory...
Researchers have put forward a unique process for 'cleaning'
volatile organic compounds - a process that could have considerable
importance to organic compounds that are used in the pharmaceutical
manufacturing process.
The chemicals industry could be revolutionalised by a new class of
environmentally friendly chemicals with the potential to replace
the use of hazardous, petroleum-based solvents in laboratories and
industrial plants.
Drug packaging maker West Pharmaceutical Services release its 3Q
results, which indicate a rise in profits but fell short of analyst
estimates, due to slow sales in some segments and high raw material
and energy costs.
Systech International's new TIPS Serialized Product Tracking
solution software will aid in the fight against counterfeit and
diverted products within the pharmaceutical and healthcare
industries.
EU environment ministers met on Monday to further debate key issues
related to the chemical substances review, which has become one of
the fiercest political battlegrounds ever in the history of EU
policy definition.
Bionovo has announced data identifying a novel class of Oestrogen
receptor-subtype modulators, which provides solid evidence of a
potentially safer alternative treatment to hormone therapy that
treats hot flashes and night sweats.
Research Dynamics have struck a deal with VirtualScopics in which
they have signed a non-exclusive partnership agreement to co-market
their clinical research services and technologies.
Dharmacon and Alcon are to collaborate on the discovery of new
therapies for eye disease using RNAi technology. The specificity
and novel molecular mechanism of RNAi may allow for the development
of safer and more effective drugs...
A recently published report has revealed that less than 13 per cent
of US consumers believe that information provided by pharmaceutical
companies is more trustworthy than healthcare information provided
by other organisations.
According to a new report, the emergence of antibacterial
resistance is set to push antibiotic R&D back into the
spotlight in an attempt to slow down the increasing levels of drug
resistance that could well erode the medical advances...
Bruker AXS, a subsidiary of the Bruker BioSciences Corporation, has
announced an agreement to purchase Roentec, an x-ray microanalysis
instrumentation company that signals Bruker's intention to
reinforce its standing within this...
Actavis's $810 million (€677 million) cash acquisition of
Alpharma's US and international generic drugs division is part of
the firm's strategy to become one of the global leaders in the
sector.
The Food and Drug Administration has approved Flexbumin, the first
human albumin preparation to be packaged in a flexible container,
reducing the risk of breakage while being more compatible with
hospital inventory storage systems.
Dutch pharmaceuticals and chemicals giant Akzo Nobel reported
third-quarter sales of €3,29 billion, a slight decrease from the
previous quarter but up 5.4 per cent from the comparable period in
2004, thanks to growth in all its units,...
Roche has formed a research collaboration with Epitomics, giving
Roche a license to Epitomics' monoclonal antibody technology
(RabMab technology) for the discovery and development of monoclonal
antibodies to treat cancer and...
New Life Scientific and CureLab have identified an anti fungal
compound that represents a significant breakthrough as part of a
joint collaboration, which has demonstrated immunostimulating and
antibacterial properties.
According to a new report, worldwide revenues for cell and cytokine
therapies in regenerative medicine are set to reach $20.7 billion
(€17.3 billion) in 2010 in a sector that provides a viable
alternative to using drugs or other therapies.
Procyon has announced preclinical results for its lead HIV protease
inhibitor that has demonstrated cross-resistance profile and
multi-drug resistant strains of HIV-1 compared to other HIV
protease inhibitors, which are fast becoming...
Olympus Microscopes announces the launch of two new microscopy
products that aims to further improve live cell imaging conditions
that characterises drug development.
Chiron has warned it will yet again fall short of targets for its
US flu vaccine deliveries this year due to continuing production
problems with its British manufacturing plant.
Sterling Biotech, India's largest gelatin producer, has struck a
deal with Gujarat Biotech (TGBL) to purchase its manufacturing unit
for Rs 55 cr ($12.3 million) in an all cash deal. Sterling's
acquisition brings it one...
The first non-injectable insulin treatment in Europe may soon
become available after a panel of experts recommended it for
regulatory approval on Thursday.
European Authorities recommended the first needle-free system for
acute postoperative pain for approval this week, which allows
patient-controlled delivery of fentanyl in post-operative pain
control.
Bangledeshi's Beximco Pharmaceuticals has announced that the
company has raised $21 million after it successfully completed an
institutional placing of global depositary receipts (GDRs).
Clinical trials for what may be the first effective culture-based
vaccine against the highly-pathogenic avian influenza viruses will
begin in Norway in Spring 2006.
Dendritic Nanotechnologies (DNT) has signed a collaboration
agreement with Nanotechnology Characterisation Laboratory (NCL),
which is focused on the discovery and development of dendrimer
technologies.
The GEA Group has acquired the manufacturer of freeze dryers for
pharmaceutical products, STERIS, a unit of US-based STERIS
Corporation in a deal that aims to strengthen the group's Process
Engineering Division in the Process...
BASF has announced it is to reduce production at one of its main
sites in a move that reflects the declining demand for
pseudoephedrine and caffeine caused by a change in prescription
regulations and pricing pressures.
A new antibiotic that not only acts as a traditional antibiotic but
also acts on bacterial infections that have developed resistance to
existing types of antibiotic could herald the emergence of a new
tool to fight infections.
Roche has launched what it claims is the first commercially
available instrument for high-throughput DNA sequencing, enabling
sequencing of genomes and long DNA sequences up to 100 x faster
than current Sanger-based methods.
Scientists have demonstrated that a mouse virus that causes mammary
cancer can infect human cells. This latest study attempts to shed
light on a debate stretching back to the early 70's, which show
that a viral-like agent may...
Drugs, which stick to a key protein in the bloodstream, could help
to create drugs that are delivered more effectively to organs in
the body. The latest research, which points to a more effective
delivery of therapy, could improve...
Researchers have discovered a species of seaweed that could yield
new compounds with pharmaceutical potential, some of which showed
the potential to kill cancer cells, bacteria and even the HIV
virus.
Materials company, Micromuscle, has developed an electro-active
polymer technology that allows the controlled release of liquid
medications that reflect an emerging class of advanced materials
with new revolutionary properties.
Pharmaceutical manufacturers, Wyeth, are to phase out manufacturing
at its US facility as part of its consolidation plans, which will
see the gradual phasing out of all operations at the New York
facility by late 2008.